Clinical Trial Update: Vancomycin Versus Ceftaroline in Patients With Infections Caused by MRSA That Are Susceptible to Ceftaroline

View source ↗

Summary

This ClinicalTrials.gov study compares vancomycin with ceftaroline in patients with MRSA infections susceptible to ceftaroline; the trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacteremia
• Bacterial Skin and Skin Structure Infections
• Methicillin-resistant Staphylococcus Aureus Infection
• Pneumonia

Drugs mentioned

• Teflaro (ceftaroline fosamil)
• Vancomycin (vancomycin)

Snippet

Sponsor: CPL Associates | Conditions: MRSA Infection, Bacteremia | Status: UNKNOWN